¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ F Bd+=bx,Z  
Y j ,9V],  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ^!zJf7(+<>  
>$d d 9|[  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© wWp?HDl"M  
.&aVx]  
1.Co-stimulators (or co-stimulating molecules) p{('KE)  
]9!Gg  
2.NK-kB PW(_yB;  
gDUoc*+h  
3.Immunoglobulin superfamily ]~4}(\u  
$~;6hnr m  
4.antigen-presenting cell (APC) ?STI8AdO  
>d1aE)?  
5.death domain 1t uator  
x3:ZB  
6.CCR and CXCR AZBY, :>D  
)%-\hl]  
7.Lectin (or mitogen) ^@l5u=  
K~9 jin  
8.Clusters of differentiation, CD) 1{Sx V  
A=@V LU4%  
9.B7 family 7ZR0M&pX  
\dQ2[Ek  
10.Cytotoxic T lymphocyte, CTL) Tk2&{S"  
a*e|>pDO  
11.IL-15 and IL-15 receptor (IL-15R) v@<lEG#$"|  
pB{ f-M:D  
12.MHC restriction QjT#GvHY  
iI/'! 85  
13.Affinity-chromatography &  t @  
<jg wdbT"6  
14.Cyctosprin A, CsA 'j =PbA  
Phjf$\pt  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) p-ii($~ }  
]'z ^Kt5S  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 22H=!.DJ  
<=LsloI  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 '@1Q x~*]e  
RdpQJ)3F  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ >G -?e!  
G5Dji_|  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ I.n{ "=$B@  
F b`7 aFIf  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© V3Rnr8  
F$pd]F!#  
ÃâÒßѧרҵ£º `5aypJf 1  
~O3uje _  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ mZ.6Njb  
,t,65@3+b  
Ïû»¯ÄÚ¿Æ£º X+G*Q}5  
?. 'oxW  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ,)\5O0 D6  
L.~]qs|G/K  
ѪҺ²¡Ñ§×¨Òµ£º F[qI fh4  
C{Xk/Er5<  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»